12-116749855-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001382266.1(RNFT2):c.98C>T(p.Ala33Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000841 in 1,426,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001382266.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNFT2 | NM_001382266.1 | c.98C>T | p.Ala33Val | missense_variant | 4/11 | ENST00000257575.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNFT2 | ENST00000257575.9 | c.98C>T | p.Ala33Val | missense_variant | 4/11 | 5 | NM_001382266.1 | P1 | |
RNFT2 | ENST00000392549.7 | c.98C>T | p.Ala33Val | missense_variant | 4/12 | 5 | P1 | ||
RNFT2 | ENST00000407967.7 | c.98C>T | p.Ala33Val | missense_variant | 4/11 | 5 | |||
RNFT2 | ENST00000547718.5 | c.*55C>T | 3_prime_UTR_variant, NMD_transcript_variant | 5/12 | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000841 AC: 12AN: 1426560Hom.: 0 Cov.: 32 AF XY: 0.00000849 AC XY: 6AN XY: 706372
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The c.98C>T (p.A33V) alteration is located in exon 4 (coding exon 3) of the RNFT2 gene. This alteration results from a C to T substitution at nucleotide position 98, causing the alanine (A) at amino acid position 33 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at